{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:40:39Z","timestamp":1770748839891,"version":"3.50.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.avsg.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T11:39:02Z","timestamp":1661168342000},"page":"182-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Midterm Outcomes of Endovascular Therapy for TASC II D Femoropopliteal Lesions with Critical Limb Ischemia: A Retrospective Analysis"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-1740","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-qi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2022.08.004_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/aoms.2012.28568","article-title":"Peripheral arterial disease of the lower extremities","volume":"8","author":"Aronow","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.avsg.2022.08.004_bib2","doi-asserted-by":"crossref","first-page":"e001946","DOI":"10.1161\/CIRCINTERVENTIONS.115.001946","article-title":"Management of critical limb ischemia","volume":"9","author":"Kinlay","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.08.004_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society Consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Society for Vascular Surgery. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib5","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jvs.2018.08.176","article-title":"Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia","volume":"69","author":"Biagioni","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/bjs.10292","article-title":"Comparison of angioplasty and bypass surgery for critical limb ischaemia in patients with infrapopliteal peripheral artery disease","volume":"103","author":"Patel","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.avsg.2018.07.060","article-title":"Long-term results of endovascular treatment of TASC C and D aortoiliac occlusive disease with expanded polytetrafluoroethylene stent graft","volume":"56","author":"Bracale","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1526602820902014","article-title":"ZILVERPASS study: ZILVER PTX stent vs bypass surgery in femoropopliteal lesions","volume":"27","author":"Bosiers","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2022.08.004_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2022.08.004_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00270-014-0876-3","article-title":"Standards of practice for superficial femoral and popliteal artery angioplasty and stenting","volume":"37","author":"Katsanos","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2022.08.004_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.avsg.2017.09.008","article-title":"Comparison of endovascular versus bypass surgery in femoropopliteal TASC II D lesions: a single-center study","volume":"47","author":"Veraldi","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jvs.2015.10.009","article-title":"In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization","volume":"63","author":"Meyer","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12872-015-0025-1","article-title":"Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study","volume":"15","author":"Guo","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.avsg.2022.08.004_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jvs.2006.08.074","article-title":"Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease","volume":"45","author":"Kedora","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib16","first-page":"392","article-title":"Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients","volume":"59","author":"Brouillet","year":"2018","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2022.08.004_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1583\/JEVT-12-3898R.1","article-title":"Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials","volume":"19","author":"Acin","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2022.08.004_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.hlc.2016.09.011","article-title":"Long-term primary patency rate after nitinol self-expandable stents implantation in long, totally occluded femoropopliteal (TASC II C & D) lesions","volume":"26","author":"Elmahdy","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.avsg.2022.08.004_bib19","first-page":"910","article-title":"VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.08.004_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejvs.2005.04.027","article-title":"Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants","volume":"30","author":"Hartung","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3400\/avd.ra.18-00006","article-title":"Hybrid operations in patients with peripheral arterial disease","volume":"11","author":"Murakami","year":"2018","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.avsg.2022.08.004_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jvs.2008.05.025","article-title":"Common femoral artery occlusive disease: contemporary results following surgical endarterectomy","volume":"48","author":"Kang","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1538574418779466","article-title":"Impact of tibial runoff on outcomes of endovascular treatment for femoropopliteal atherosclerotic lesions","volume":"52","author":"Park","year":"2018","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.avsg.2008.04.007","article-title":"Percutaneous superficial femoral artery interventions for claudication--does runoff matter?","volume":"22","author":"Davies","year":"2008","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejvs.2006.07.016","article-title":"Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia","volume":"32","author":"Lazaris","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.08.004_bib26","doi-asserted-by":"crossref","first-page":"e002730","DOI":"10.1161\/CIRCINTERVENTIONS.115.002730","article-title":"Femoropopliteal artery stent thrombosis: report from the excellence in peripheral artery disease registry","volume":"9","author":"Banerjee","year":"2016","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622005040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622005040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:03Z","timestamp":1760188083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509622005040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"alternative-id":["S0890509622005040"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2022.08.004","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midterm Outcomes of Endovascular Therapy for TASC II D Femoropopliteal Lesions with Critical Limb Ischemia: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}